BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/14/2025 10:52:09 AM | Browse: 7 | Download: 22
 |
Received |
|
2025-05-06 03:20 |
|
Peer-Review Started |
|
2025-05-07 00:06 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-05-17 15:44 |
|
Revised |
|
2025-05-20 13:18 |
|
Second Decision |
|
2025-07-18 02:50 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-07-18 09:09 |
|
Articles in Press |
|
2025-07-18 09:09 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-08-04 03:23 |
|
Publish the Manuscript Online |
|
2025-08-14 10:52 |
| ISSN |
1948-9358 (online) |
| Open Access |
The first time an abbreviation appears in the manuscript, please label it with its full name. |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Ophthalmology |
| Manuscript Type |
Minireviews |
| Article Title |
Role of alternative oral therapy for the management of wet age-related macular degeneration and proliferative diabetic retinopathy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Shweta Walia, Arvind Kumar Morya, Srishti Khullar, Sarita Aggarwal and Rajwinder Kaur |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Arvind Kumar Morya, Academic Editor, MD, Professor, Research Assistant Professor, Senior Researcher, Department of Ophthalmology, All India Institute of Medical Sciences, Bibi Nagar, Hyderabad 508126, Telangana, India. bulbul.morya@gmail.com |
| Key Words |
Proliferative diabetic retinopathy; Wet age-related macular degeneration; Anti-angiogenesis; Oral therapy; Fenofibrate; Candesartan; Vorolanib; Diabetic macular edema; Systemic treatment; Retinal neovascularization |
| Core Tip |
Anti-vascular endothelial growth factor injections are effective for proliferative diabetic retinopathy (PDR) and wet age-related macular degeneration (ARMD), but patient compliance and healthcare strain limit their utility. This review explores the role of oral drugs such as fenofibrate, candesartan, and vorolanib in the management of PDR and wet ARMD. These agents offer ease of administration and may serve as adjuncts or substitutes for injection-averse patients. Further multicenter randomized controlled trials are warranted to confirm long-term safety and efficacy. |
| Publish Date |
2025-08-14 10:52 |
| Citation |
<p>Walia S, Morya AK, Khullar S, Aggarwal S, Kaur R. Role of alternative oral therapy for the management of wet age-related macular degeneration and proliferative diabetic retinopathy. <i>World J Diabetes</i> 2025; 16(8): 109231</p> |
| URL |
https://www.wjgnet.com/1948-9358/full/v16/i8/109231.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v16.i8.109231 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
